Live Database

Opportunities
Search

Search the internal Cuberfy opportunities database for grants, startup programs, tenders, cloud credits and funding calls.

Searching the internal opportunities database and preparing the best matching records.
All Tenders Grants Funding Projects
46366 opportunities · Page 1639 of 1855
Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol, Beclometason, Glycopyrronium, f. d. Z. 01.11.25 - 31.10.26 (zzgl. Verlängerungsoption 1x12 Mon)
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glycopyrroniumbromid, ATC R03BB06 für die Zeit 01.11.2025 - 31.10.2026 (zzgl. Verlängerungsoption 1x12 Mon)
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Birkenpollen ausschießlich Dafo SUT, ATC V01AA05 für die Zeit 01.11.2025 - 31.10.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Raltegravir, ATC J05AJ01 für die Zeit 01.11.2025 - 31.10.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tiotropiumbromid ausschließlich in der Dafo Lösung zur Inhalation, ATC R03BB04 f. d. Z. 01.11.25 - 31.10.27
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
ted.europa.eu
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin beta, ATC G03GA06 für die Zeit 01.11.2025 - 31.10.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natriumphenylbutyrat, ATC A16AX03 für die Zeit 01.11.2025 - 31.10.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Filgotinib, ATC L04AF04 für die Zeit 01.11.2025 - 31.10.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05
TEN
Lithuania – Crossheads – 31616 Geležinkelio iešmai
ted.europa.eu
Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-09-05
Tender Procurement Contract Lithuania Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 5, 2027
Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-09-05
TEN
Lithuania – Translation services – Vertimo paslaugų užsakymai per CPO LT elektroninį katalogą
ted.europa.eu
Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-09-06
Tender Procurement Contract Lithuania Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 6, 2027
Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-09-06
GRA
FAA Aviation Research Grants Program
grants.gov
The FAA hereby announces its continuing interest in receiving applications for aviation research grants and cooperative agreements to pursue the long-...
Grant Mixed United States Open
AmountAward range: $0 - $6,000,000
DeadlineSep 7, 2027
The FAA hereby announces its continuing interest in receiving applications for aviation research grants and cooperative agreements to pursue the long-term growth and short-term technical needs of civil aviation, under this funding opportunity. Eligibility of applicants for the award of an aviation research grant varies depending on the nature of the proposer's organization, as well as the character of the research being proposed. In general, colleges, universities, and other non- profit research institutions under Section 501(c)(3) of Title 26 of United States Code, are eligible to apply for an aviation research grant. The FAA Aviation Research Grants Program encourages and supports innovative, advanced research of potential benefit to the long-term growth of civil aviation and commercial space transportation. The pursuit of basic and applied research in scientific and engineering disciplines that have the potential to further knowledge and understanding on a broad front of emerging te...
GRA
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
grants.gov
The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scient...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 7, 2027
The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
GRA
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
grants.gov
This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accele...
Grant Mixed United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 7, 2027
This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.
GRA
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
grants.gov
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics,...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 7, 2027
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.
GRA
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
grants.gov
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics,...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 7, 2027
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.
GRA
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
grants.gov
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities o...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 7, 2027
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.
GRA
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
grants.gov
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities o...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 7, 2027
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.
GRA
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
grants.gov
This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025. The objective...
Grant Cash Grant United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 7, 2027
This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025. The objective of this funding opportunity is to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce health disparities for other health outcomes among populations that experience health disparities.
GRA
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
grants.gov
Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addictio...
Grant Cash Grant United States Open
AmountAward ceiling: $100,000
DeadlineSep 7, 2027
Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to ex...
RES
MSCA Postdoctoral Fellowships 2027
ec.europa.eu
Expected Outcome:Project results are expected to contribute to the following outcomes:For supported postdoctoral fellowsIncreased set of research and...
Research Funding Cash Grant Europe Open
AmountNot provided on the source page. Please check the official source.
DeadlineSep 8, 2027
Expected Outcome:Project results are expected to contribute to the following outcomes:For supported postdoctoral fellowsIncreased set of research and transferable skills and competences, leading to improved employability and career prospects of MSCA postdoctoral fellows within academia and beyond;New mind-sets and approaches to R&I work forged through international, inter-sectoral and interdisciplinary experience;Enhanced networking and communication capacities with scientific peers, as well as with the general public that will increase and broaden the research and innovation impact. For participating organisationsIncreased alignment of working conditions for researchers in accordance with the principles set out in the European Charter for Researchers;Enhanced quality and sustainability of research training and supervision;Increased global attractiveness, visibility and reputation of the...
RES
ERA Fellowships
ec.europa.eu
Expected Outcome:This action builds on the MSCA Postdoctoral Fellowships 2027 action (HORIZON-MSCA-PF-2027). The target group are host organisations l...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 100,000 EUR - 500,000 EUR
DeadlineSep 8, 2027
Expected Outcome:This action builds on the MSCA Postdoctoral Fellowships 2027 action (HORIZON-MSCA-PF-2027). The target group are host organisations located in Widening countries.Project results are expected to contribute to the following outcomes:For supported ERA Fellows:Increased set of research and transferable skills and competences, leading to improved employability and career prospects of fellows within academia and beyond;New mind-sets and approaches to R&I work forged through international, inter-sectoral and interdisciplinary experience;Enhanced networking and communication capacities with scientific peers, as well as with the general public, that will increase and broaden the research and innovation impact; For participating organisations in the Widening countries:Increased alignment of working conditions for researchers in accordance with the principles set out in the Europea...
📅 Best viewed on desktop - or rotate your phone to landscape mode.
# Opportunity Type Region / Country Amount Deadline Source
40951 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol, Beclometason, Glycopyrronium, f. d. Z. 01.11.25 - 31.10.26 (zzgl. Verlängerungsoption 1x12 Mon) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40952 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glycopyrroniumbromid, ATC R03BB06 für die Zeit 01.11.2025 - 31.10.2026 (zzgl. Verlängerungsoption 1x12 Mon) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40953 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Allergenextrakt aus Birkenpollen ausschießlich Dafo SUT, ATC V01AA05 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40954 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Raltegravir, ATC J05AJ01 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40955 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tiotropiumbromid ausschließlich in der Dafo Lösung zur Inhalation, ATC R03BB04 f. d. Z. 01.11.25 - 31.10.27 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40956 Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40957 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Follitropin beta, ATC G03GA06 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40958 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natriumphenylbutyrat, ATC A16AX03 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40959 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Filgotinib, ATC L04AF04 für die Zeit 01.11.2025 - 31.10.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40960 Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40961 Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-09 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40962 Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-09-05

40963 Lithuania – Crossheads – 31616 Geležinkelio iešmai Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-... Tender Procurement Contract Lithuania Not provided on the source page. Please check the official source. Open Sep 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: LTG Kompetencijų centras UAB (PV) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-09-05

40964 Lithuania – Translation services – Vertimo paslaugų užsakymai per CPO LT elektroninį katalogą Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-09-06 Tender Procurement Contract Lithuania Not provided on the source page. Please check the official source. Open Sep 6, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-09-06

40965 FAA Aviation Research Grants Program The FAA hereby announces its continuing interest in receiving applications for aviation research grants and cooperative agreements... Grant Mixed United States Award range: $0 - $6,000,000 Open Sep 7, 2027 Open Grants.gov
Source description

The FAA hereby announces its continuing interest in receiving applications for aviation research grants and cooperative agreements to pursue the long-term growth and short-term technical needs of civil aviation, under this funding opportunity. Eligibility of applicants for the award of an aviation research grant varies depending on the nature of the proposer's organization, as well as the character of the research being proposed. In general, colleges, universities, and other non- profit research institutions under Section 501(c)(3) of Title 26 of United States Code, are eligible to apply for an aviation research grant. The FAA Aviation Research Grants Program encourages and supports innovative, advanced research of potential benefit to the long-term growth of civil aviation and commercial space transportation. The pursuit of basic and applied research in scientific and engineering disciplines that have the potential to further knowledge and understanding on a broad front of emerging technologies is crucial to the realization of this goal. The intent is to encourage appliedresearch and development to enhance technology assimilation, transfer, and development in the FAA. The FAA Aviation Research Grants Program does not require the immediate application to Research and Development (R&D) programs, although this may occur in some cases. The FAA encourages thesubmission of proposals that embrace the entire spectrum of physical, chemical, biological, medical, psychological, mathematical, and engineering sciences. The following list illustrates topics of interest to those who may....

40966 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public heal... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Sep 7, 2027 Open Grants.gov
Source description

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

40967 Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial inv... Grant Mixed United States Not provided on the source page. Please check the official source. Open Sep 7, 2027 Open Grants.gov
Source description

This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.

40968 Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in comp... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Sep 7, 2027 Open Grants.gov
Source description

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.

40969 Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in comp... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Sep 7, 2027 Open Grants.gov
Source description

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early-stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All applications should address how the methods would scale to address increasingly larger data sets.

40970 Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualiz... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Sep 7, 2027 Open Grants.gov
Source description

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.

40971 Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualiz... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Sep 7, 2027 Open Grants.gov
Source description

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.

40972 Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25,... Grant Cash Grant United States Not provided on the source page. Please check the official source. Open Sep 7, 2027 Open Grants.gov
Source description

This PAR is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025. The objective of this funding opportunity is to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce health disparities for other health outcomes among populations that experience health disparities.

40973 D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of... Grant Cash Grant United States Award ceiling: $100,000 Open Sep 7, 2027 Open Grants.gov
Source description

Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to expedite the development of robust research programs focused on the convergence of innovative data science techniques and addiction research, with initial projects serving as precursors for subsequent, more expansive research projects.

40974 MSCA Postdoctoral Fellowships 2027 Expected Outcome:Project results are expected to contribute to the following outcomes:For supported postdoctoral fellowsIncreased... Research Funding Cash Grant Europe Not provided on the source page. Please check the official source. Open Sep 8, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Project results are expected to contribute to the following outcomes:For supported postdoctoral fellowsIncreased set of research and transferable skills and competences, leading to improved employability and career prospects of MSCA postdoctoral fellows within academia and beyond;New mind-sets and approaches to R&I work forged through international, inter-sectoral and interdisciplinary experience;Enhanced networking and communication capacities with scientific peers, as well as with the general public that will increase and broaden the research and innovation impact. For participating organisationsIncreased alignment of working conditions for researchers in accordance with the principles set out in the European Charter for Researchers;Enhanced quality and sustainability of research training and supervision;Increased global attractiveness, visibility and reputation of the...

40975 ERA Fellowships Expected Outcome:This action builds on the MSCA Postdoctoral Fellowships 2027 action (HORIZON-MSCA-PF-2027). The target group are... Research Funding Cash Grant Europe Expected EU contribution: 100,000 EUR - 500,000 EUR Open Sep 8, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:This action builds on the MSCA Postdoctoral Fellowships 2027 action (HORIZON-MSCA-PF-2027). The target group are host organisations located in Widening countries.Project results are expected to contribute to the following outcomes:For supported ERA Fellows:Increased set of research and transferable skills and competences, leading to improved employability and career prospects of fellows within academia and beyond;New mind-sets and approaches to R&I work forged through international, inter-sectoral and interdisciplinary experience;Enhanced networking and communication capacities with scientific peers, as well as with the general public, that will increase and broaden the research and innovation impact; For participating organisations in the Widening countries:Increased alignment of working conditions for researchers in accordance with the principles set out in the Europea...